What's happening
This bill allows optometrists in New York to use nasal sprays as topical therapeutic agents for treating dry eye disease.
Why it matters
Expands Treatment Options for Patients. By allowing optometrists to use nasal sprays as topical agents, patients with dry eye disease gain access to newer or alternative therapies without needing to see a different type of healthcare provider.
Increases Convenience and Access to Care. Optometrists are often the first point of contact for eye issues; this change lets them more efficiently address dry eye disease with all available tools, potentially reducing delays and extra appointments.
Reflects Advances in Medical Technology. The amendment acknowledges recent scientific developments in treating eye conditions, ensuring that optometrists’ scope of practice keeps pace with innovations like nasal spray treatments.
May Influence Insurance and Cost Dynamics. As optometrists are authorized to administer these medications, insurance coverage and out-of-pocket costs for patients could be affected, possibly making new treatments more accessible or affordable.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Optometrists
The bill would expand their authorized topical therapeutic pharmaceutical agents to include drugs listed in section 7101-a(1)(f)(iii) administered by nasal spray to treat dry eye disease.
Patients with dry eye disease
The bill would allow optometrists to use the specified nasal-spray drugs to treat their condition.
Manufacturers of nasal-spray dry eye treatments
Their drugs could fall within optometrists’ authorized treatments if listed in the provision referenced by the bill.
Headline styles
Let Optometrists Use Nasal Sprays
Plain English, a few words. Used as the page title.
Sponsors
1 Co-sponsor
History
- Signed chap.516
- Delivered to governor
- Returned to senate
- Passed assembly
- Ordered to third reading rules cal.276
- Substituted for A9902
- Referred to higher education
- Delivered to assembly
- Passed senateVote 61–0
- Advanced to third reading
- 2nd report cal.
- 1st report cal.986
Show 3 earlier actions
- Print number 8768a
- Amend and recommit to higher education
- Referred to higher education
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Allow Nasal Sprays for Optometrists
Assembly Floor Calendar · Sponsor John T. McDonald III
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
8768--A
IN SENATE
March 8, 2024
Introduced by Sen. WEBB -- read twice and ordered printed, and when printed to be committed to the Committee on Higher Education -committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee
AN ACT to amend the education law, in relation to including nasal sprays in topical therapeutic pharmaceutical agents optometrists are authorized to use
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision 1 of section 7101-a of the education law is amended by adding a new paragraph (e-1) to read as follows:
(e-1) Nasal sprays as topical therapeutic pharmaceutical agents. Topical therapeutic pharmaceutical agents shall also include those drugs listed in subparagraph (iii) of paragraph (f) of this subdivision that are administered through a nasal spray for the treatment of dry eye disease.
§ 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD14764-02-4
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the education law, in relation to including nasal sprays in topical therapeutic pharmaceutical agents optometrists are authorized to use
Purpose
Includes nasal sprays in topical therapeutic pharmaceutical agents opto- metrists are authorized to use
Summary of provisions
Section1: Amends subdivision 1 of Section 7101-a of the education law by adding a new paragraph defining nasal sprays for the treatment of dry eye disease as topical therapeutic pharmaceutical agents.
Section 2: Effective date.
Justification
This bill would ensure that optometry patients in every area of the state would have access to a new, potentially more effective treatment for dry eye disease. Currently in New York, only ophthalmologists are authorized to prescribe a nasal spray for the treatment of this disease. There are a number of counties in New York that do not have ophthalmolo- gists available and patients in those counties rely on optometrists as their first line of defense against eye care and vision problems. The statute related to optometric scope of practice currently limits pres- criptive authority for dry eye disease to "direct to the eye" medica- tions, such as eye drops or topical medications. This precludes patients in New York with dry eye disease who see an optometrist for their eye care from using newer FDA approved topical treatments, including one that is administered through a nasal spray.
Legislative history
New bill.
Fiscal implications
None.
Effective date
Immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.